Cellular immune responses to four doses of percutaneous bacille Calmette-Guérin in healthy adults.
Cellular immune responses to four doses of percutaneous bacille Calmette-Guérin in healthy adults.
复制标题
健康成人对四剂经皮卡介苗的细胞免疫反应。
DOI:
10.1086/515614
复制
发表时间:
1998
期刊:
影响因子:
--
通讯作者:
JacobsJr,DR
中科院分区:
文献类型:
--
作者:
Lowry,PW;Ludwig,TS;Adams,JA;Fitzpatrick,ML;Grant,SM;Andrle,GA;Offerdahl,MR;Cho,SN;JacobsJr,DR
To explore the hypothesis that low-dose immunization might induce preferential Th1 cell immunity, 76 adults were vaccinated with one of four doses of bacille Calmette-Guérin (BCG): The doses contained very low (1.6 × 105cfu), low (3.2 × 106cfu), standard (1.6 × 108cfu), or high (3.2 × 108cfu) levels of BCG. Delayed-type hypersensitivity responses occurred 8 weeks after vaccination in 10% of persons given very low or low doses of BCG, compared with 95% and 100% of persons given standard or high doses, respectively. Lymphoproliferative responses, which were increased only for high-dose vaccinees, peaked 2 weeks after vaccination and were directed chiefly againstMycobacterium tuberculosis-secreted proteins, particularly the antigen 85 complex. Significant increases in mycobacteria-specific interferon-γ expression were present 16 weeks after vaccination only for persons given standard or high doses of BCG. Percutaneous BCG appears capable of inducing a temporary Th1-like immune response, but standard or higher dosages are required.